FIELD: medicine.
SUBSTANCE: on 20-24 day of menstrual cycle additional analysis of vascular-endothelial growth-factor (VEGF), homocysteine, endothelin, plasminogen activation inhibitor of first type (PAI-1), tissue plasminogen activator (t-PA) is carried out and if they correspond to the norm of vascular-endothelial growth factor (VEGF) within 30-600 pg/ml, homocysteine 5-12 mcmol/l, endothelin 8-14 fmol/ml, plasminogen activation inhibitor of first type (PAI-1) 7-40 ng/ml, tissue plasminogen activator (t-PA) 5-12 ng/ml, conclusion about readiness of woman's hemostasis system for inclusion into programme of extracorporal fertilisation and transfer of embryo is made.
EFFECT: method makes it possible to increase efficiency of programme of extracorporal fertilisation and transfer of embryo due to correcting therapy of hemostasis parameters in case of necessity.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF PREGNANCY IN WOMEN WITH "POOR" RESPONSE USING BLOOD SERUM | 2023 |
|
RU2816049C1 |
| METHOD FOR CORRECTION OF HAEMOSTASIS DISORDERS IN FEMALES ACCOMPANYING EXTRACORPOREAL FERTILIZATION | 2018 |
|
RU2723358C2 |
| METHOD FOR PREDICTION OF IMPLANTATION IN PROGRAMS OF ANCILLARY REPRODUCTIVE TECHNOLOGY IN WOMEN OF SENIOR REPRODUCTIVE AGE WITH TUBOPERITONEAL INFERTILITY FACTOR | 2020 |
|
RU2735218C1 |
| METHOD FOR PREDICTION OF ENDOMETRIAL RECEPTIVITY IN IN VITRO FERTILISATION CYCLES | 2014 |
|
RU2562559C1 |
| METHOD FOR PREDICTING ECF AND ET PROGRAM RESULTS | 2004 |
|
RU2273031C1 |
| METHOD FOR NON-INVASIVE ASSESSMENT OF ENDOMETRIAL RECEPTIVITY DURING IN VITRO FERTILISATION | 2023 |
|
RU2817061C1 |
| METHOD FOR DETERMINING PROBABILITY OF PREGNANCY DURING IN VITRO FERTILISATION | 2023 |
|
RU2817062C1 |
| METHOD FOR PREDICTING THE PERFORMANCE OF THE IN VITRO FERTILIZATION PROGRAM | 2017 |
|
RU2646822C1 |
| METHOD FOR APPLYING EXTRACORPORAL FERTILIZATION | 1999 |
|
RU2181581C2 |
| METHOD FOR PREDICTION OF PREGNANCY | 2012 |
|
RU2503000C2 |
